Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 2017, Article ID 9015914, 9 pages
https://doi.org/10.1155/2017/9015914
Research Article

Risk Factors of Mortality from All Asbestos-Related Diseases: A Competing Risk Analysis

1Catalan Health Institute (ICS), Division of Primary Health Care, Department of Health, Barcelona, Catalonia, Spain
2Primary Care Research Institute (IDIAP Jordi Gol) and Research Associate, Autonomous University of Barcelona (UAB), Cerdanyola del Vallès, Spain
3Catalan Institute for Medical Evaluation (ICAM), Barcelona, Catalonia, Spain
4Pneumology Unit, Hospitals de Girona i Salt, Institut d’Investigació Biomèdica de Girona (IDIBGI), Girona, Catalonia, Spain
5Ciber de Enfermedades Respiratorias (CIBERES), Palma de Mallorca, Baleares, Spain
6Palliative Care Unit, Parc Taulí Hospital, Barcelona, Spain
7Department of Public Health, University of Barcelona (UB), Barcelona, Spain
8Department of Epidemiology and Biostatistics, College of Public Health, University of South Florida, Tampa, FL, USA

Correspondence should be addressed to Rafael Abós-Herràndiz; moc.liamg@har52042

Received 29 January 2017; Revised 8 May 2017; Accepted 17 May 2017; Published 7 June 2017

Academic Editor: Elisa Giovannetti

Copyright © 2017 Rafael Abós-Herràndiz et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. International Agency for Research on Cancer, “Overall evaluations of carcinogenicity: an updating of IARC monographs,” IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, vol. 1, supplement 7, no. 42, pp. 106–117, 1987. View at Google Scholar
  2. J. Peto, A. Decarli, C. la Vecchia, F. Levi, and E. Negri, “The European mesothelioma epidemic,” British Journal of Cancer, vol. 79, no. 3-4, pp. 666–672, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. “Preventing diseases through healthy environments,” Tech. Rep. 343, World Health Organisation, Geneva, Switzerland, July 2010, http://apps.who.int/iris/bitstream/10665/204585/1/9789241565196_eng.pdf?ua=1.
  4. L. Stayner, L. S. Welch, and R. Lemen, “The worldwide pandemic of asbestos-related diseases,” Annual Review of Public Health, vol. 34, pp. 205–216, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Artieda, A. Beloqui, and M. Lezaun, “Cohorte poblacional de trabajadores expuestos a amianto: Navarra 1999-2004,” Anales del Sistema Sanitario de Navarra, vol. 28, no. 3, pp. 1–12, 2005. View at Publisher · View at Google Scholar
  6. M. Garcia, A. Menéndez, and R. Castañeda, “Incidencia en España de la Asbestosis y otras enfermedades pulmonares benignas debidas al amianto durante el período 1962-2010,” Rev Esp Salud Pública, vol. 86, pp. 613–625, 2012. View at Google Scholar
  7. J. Peto, F. E. Matthews, J. T. Hodgson, and J. R. Jones, “Continuing increase in mesothelioma mortality in Britain,” The Lancet, vol. 345, no. 8949, pp. 535–539, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Magnani, F. Mollo, L. Paoletti et al., “Asbestos lung burden and asbestosis after occupational and environmental exposure in an asbestos cement manufacturing area: a necropsy study,” Occupational and Environmental Medicine, vol. 55, no. 12, pp. 840–846, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. D. W. Kamp, “Asbestos-induced lung diseases: an update,” Translational Research, vol. 153, no. 4, pp. 143–152, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Tarrés, C. Albertí, X. Martínez-Artés et al., “Pleural mesothelioma in relation to meteorological conditions and residential distance from na industrial source of asbestos,” Occupational and Environmental Medicine, vol. 70, no. 8, pp. 588–590, 2013. View at Publisher · View at Google Scholar
  11. M. Ray and H. L. Kindler, “Malignant pleural mesothelioma: an update on biomarkers and treatment,” Chest, vol. 136, no. 3, pp. 888–896, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. I. J. Selikoff, J. Churg, and E. C. Hammond, “Asbestos exposure and neoplasia,” JAMA: The Journal of the American Medical Association, vol. 188, no. 1, pp. 22–26, 1964. View at Publisher · View at Google Scholar · View at Scopus
  13. I. J. Selikoff, J. Churg, and E. C. Hammond, “Asbestos Exposure and Neoplasia,” JAMA, vol. 188, no. 1, pp. 48–56, 1964. View at Publisher · View at Google Scholar
  14. G. Frost, A.-H. Harding, A. Darnton, D. McElvenny, and D. Morgan, “Occupational exposure to asbestos and mortality among asbestos removal workers: a poisson regression analysis,” British Journal of Cancer, vol. 99, no. 5, pp. 822–829, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Bianchi and T. Bianchi, “Malignant mesothelioma: global incidence and relationship with asbestos,” Industrial Health, vol. 45, no. 3, pp. 379–387, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. McCormack, J. Peto, G. Byrnes, K. Straif, and P. Boffetta, “Estimating the asbestos-related lung cancer burden from mesothelioma mortality,” British Journal of Cancer, vol. 106, no. 3, pp. 575–584, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. “Elimination of Asbestos Related Disease,” Tech. Rep., World Health Organisation, Geneve, Switzerland, 2006, http://apps.who.int/iris/bitstream/10665/69479/1/WHO_SDE_OEH_06.03_eng.pdf.
  18. http://www.idescat.cat/emex/?id=081803#h1000000.
  19. J. Tarrés, R. Abós-Herràndiz, C. Albertí et al., “Enfermedad por amianto en una población próxima a una fábrica de fibrocemento,” Archivos de Bronconeumología, vol. 45, no. 9, pp. 429–434, 2009. View at Publisher · View at Google Scholar
  20. M. Rosell-Murphy, R. Abás-Herrndiz, J. Tarrés et al., “Prospective study of asbestos-related diseases incidence cases in primary health care in an area of Barcelona province,” BMC Public Health, vol. 10, article no. 203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. American Thoracic Society Documents, “Diagnosis and initial management of non-malignant diseases related to asbestos,” American Journal of Respiratory and Critical Care Medicine, vol. 170, no. 6, pp. 691–715, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. R. Abós-Herràndiz, A. Puigdefàbregas-Serra, R. Gispert-Magaroles et al., “Classification and codes of asbestos related diseases: from a small scale to a global view,” in Proceedings of the WHO family of international classifications annual network meeting, Brasilia, Brasil, 2012, http://www.who.int/classifications/network/PosterBooklet.zip?ua=1.
  23. K. J. Rothamn and S. Greenland, “Causation and causal inference,” in Modern Epidemiology, K. J. Rothman and S. Greenland, Eds., pp. 7–28, Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2nd edition, 1998. View at Google Scholar
  24. E. L. Kaplan and P. Meier, “Nonparametric estimation from incomplete observations,” Journal of the American Statistical Association, vol. 53, pp. 457–481, 1958. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  25. J. P. Fine and R. J. Gray, “A proportional hazards model for the subdistribution of a competing risk,” Journal of the American Statistical Association, vol. 94, no. 446, pp. 496–509, 1999. View at Publisher · View at Google Scholar · View at MathSciNet · View at Scopus
  26. B. Lau, S. R. Cole, and S. J. Gange, “Competing risk regression models for epidemiologic data,” American Journal of Epidemiology, vol. 170, no. 2, pp. 244–256, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Greenland, “Application of stratified analysis methods,” in Modern Epidemiology, K. J. Rothman and S. Greenland, Eds., pp. 281–300, Lippincott Williams & Wilkins, Philadelphia, PA, USA, 2nd edition, 1998. View at Google Scholar
  28. “Ley orgánica 15/1999, de 13 de diciembre, de protección de datos de carácter personal,” https://www.boe.es/boe/dias/1999/12/14/pdfs/A43088-43099.pdf.
  29. J.-C. Pairon, F. Laurent, M. Rinaldo et al., “Pleural plaques and the risk of pleural mesothelioma,” Journal of the National Cancer Institute, vol. 105, no. 4, pp. 293–301, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. S. Kumagai and N. Kurumatani, “Asbestos fiber concentration in the area surrounding a former asbestos cement plant and excess mesothelioma deaths in residents,” American Journal of Industrial Medicine, vol. 52, no. 10, pp. 790–798, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Dodoli, M. D. Nevo, C. Fiumalbi et al., “Environmental household exposures to asbestos and occurrence of pleural mesothelioma,” American Journal of Industrial Medicine, vol. 21, no. 5, pp. 681–687, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Ferrante, M. Bertolotti, A. Todesco, D. Mirabelli, B. Terracini, and C. Magnani, “Cancer mortality and incidence of mesothelioma in a cohort of wives of asbestos workers in Casale Monferrato, Italy,” Environmental Health Perspectives, vol. 115, no. 10, pp. 1401–1405, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. Å. Helland, S. Solberg, and O. T. Brustugun, “Incidence and survival of malignant pleural mesothelioma in Norway: a population-based study of 1686 cases,” Journal of Thoracic Oncology, vol. 7, no. 12, pp. 1858–1861, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. J. Ameille, P. Brochard, M. Letourneux, C. Paris, and J.-C. Pairon, “Asbestos-related cancer risk in patients with asbestosis or pleural plaques,” Revue des Maladies Respiratoires, vol. 28, no. 6, pp. e11–e17, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. L. J.-H. Lee, Y.-Y. Chang, S.-H. Liou, and J.-D. Wang, “Estimation of benefit of prevention of occupational cancer for comparative risk assessment: Methods and examples,” Occupational and Environmental Medicine, vol. 69, no. 8, pp. 582–586, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. E. T. Elkiran, M. A. Kaplan, A. Sevinc et al., “Multicentric study on malignant pleural mesothelioma in Turkey: Clinicopathologic and survival characteristics of 282 patients,” Medical Oncology, vol. 29, no. 5, pp. 3147–3154, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. K. J. Rothman and S. Greenland, “Cohort studies,” in Modern Epidemiology, K. J. Rothman and S. Greenland, Eds., pp. 79–92, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 2nd edition, 1998. View at Google Scholar
  38. H. Schreier, Asbestos in The Natural Environment, Elsevier, Amsterdam, The Netherlands, 1989.
  39. J. M. Mata-Perelló, “Els minerals de Catalunya. Jaciments d’amiant a Catalunya. Barcelona,” Institut d'Estudis Catalans, 1990. View at Google Scholar
  40. G. López-Abente, R. Ramis, M. Pollán et al., “Área de Epidemiología Ambiental y Cáncer del Centro Nacional de Epidemiología,” Atlas municipal de mortalidad por cáncer 1989-1998, 2007. View at Google Scholar
  41. Y. Hosoda, Y. Hiraga, and S. Sasagawa, “Railways and asbestos in Japan (1928-1987) - epidemiology of pleural plaques, malignancies and pneumoconioses,” Journal of Occupational Health, vol. 50, no. 4, pp. 297–307, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. H. I. Pass, “Pleural mesothelioma in 2002: Going somewhere very slowly,” Journal of Thoracic and Cardiovascular Surgery, vol. 124, no. 6, pp. 1074–1077, 2002. View at Publisher · View at Google Scholar · View at Scopus
  43. N. P. Campbell and H. L. Kindler, “Update on malignant pleural mesothelioma,” Seminars in Respiratory and Critical Care Medicine, vol. 32, no. 1, pp. 102–110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. Don de Savigny and A. Taghreed, Eds., Systems thinking for health systems strengthening. Alliance for Health Policy and systems Research, World Health Organisation, 2009.
  45. M. Ross, A. M. Langer, G. L. Nord et al., “The mineral nature of asbestos,” Regulatory Toxicology and Pharmacology, vol. 52, no. 1, pp. S26–S30, 2008. View at Publisher · View at Google Scholar · View at Scopus
  46. C. Ramazzini, “Editorial Board of the American Journal of Industrial Medicine,” American Journal of Industrial Medicine, vol. 36, pp. 227–229, 1999. View at Google Scholar
  47. E.-K. Park, K. Takahashi, Y. Jiang, M. Movahed, and T. Kameda, “Elimination of asbestos use and asbestos-related diseases: an unfinished story,” Cancer Science, vol. 103, no. 10, pp. 1751–1755, 2012. View at Publisher · View at Google Scholar · View at Scopus